FDA to crack down on risky stem cell offerings

November 16, 2017 by Matthew Perrone
US health agency to crack down on risky stem cell offerings
In this Dec. 5, 2014 file photo, a doctor injects a patient with a solution he says is rich in adult stem cells, at his practice in Beverly Hills, Calif. On Thursday, Nov. 16, 2017, the Food and Drug Administration laid out a strategy for regulating cell-based medicine, amid an effort to police a burgeoning medical field that has received little oversight. (AP Photo/Raquel Maria Dillon)

U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received little oversight.

The Food and Drug Administration laid out a strategy for regulating cell-based medicine, including hundreds of private clinics that have opened across the nation in the last decade. Many of the businesses promote stem cell injections for dozens of diseases including arthritis, multiple sclerosis and even Alzheimer's. They can cost $5,000 to $50,000, but there's little research that such procedures are safe or effective.

Researchers for years have called for a crackdown. FDA officials said they will focus their enforcement efforts on "bad actors" who inject stem cell mixtures into the bloodstream, nervous system or eyes. Regulators say those procedures pose the biggest risk to patients.

"We're going to be prioritizing places where we see products—not just being promoted inappropriately—but putting patients at potential risk," FDA Commissioner Scott Gottlieb told reporters on a conference call.

Gottlieb said the agency plans to use discretion in overseeing lower-risk procedures such as injections for achy joints, adding that this approach would allow the agency to get the "most bang for our regulatory buck." He also said the agency needs to be "nimble and creative" in its regulation to encourage legitimate researchers in the field.

Stem cells have long been recognized for their ability to reproduce and regenerate tissue. And while emerging research suggests that they will eventually be used to treat a range of debilitating diseases, they are currently only approved for a handful of medical procedures. For instance, adult stem cells from bone marrow transplants have long been used to treat leukemia and other blood diseases.

Most of the new clinics offer adults stem cells isolated from fat. Practitioners collect the fluid from patients via liposuction, treat it with chemicals and then inject it back into the body to treat various conditions.

Three Florida women were left nearly or completely blind by one such fat-based procedure, according to a report published earlier this year in the New England Journal of Medicine. The Florida Medical board previously revoked the license of another stem cell practitioner after two patients died under his care after receiving IV drips of stem cells to the bloodstream.

In August the FDA took action against clinics in Florida and California. The agency issued a warning letter to Sunrise, Florida-based US Stem Cell Clinic for marketing unapproved procedures for heart disease, Parkinson's disease and other conditions. And U.S. marshals, under FDA instructions, seized vials of an unproven vaccine from StemImmune Inc. of San Diego.

The FDA's authority to regulate stem cell procedures is a murky area that has been debated for years.

Typically the agency does not regulate individual doctors or their in-office procedures, focusing instead on products developed by drug and medical device manufacturers. But FDA has asserted its authority in certain cases when doctors begin processing stem cells and marketing them to treat serious diseases.

Guidelines released by the agency Thursday aim to clarify how much processing cells can undergo before triggering FDA regulation.

Explore further: FDA cites 'Significant deviations' at florida stem cell clinic

Related Stories

FDA cites 'Significant deviations' at florida stem cell clinic

August 29, 2017
(HealthDay)—A Florida stem cell clinic has received a warning letter from the U.S. Food and Drug Administration about what the agency describes as serious problems that could pose health risks to patients.

Experts: Unproven stem cell procedures need more oversight

September 9, 2015
Federal officials need to do more to prevent for-profit stem cell clinics from exploiting and potentially injuring patients, according to an article published in a leading medical journal.

Finally, unproven stem cell clinic practices might be curtailed

October 27, 2017
In a welcomed move, the Therapeutic Goods Administration (TGA) has this week announced reforms will be introduced in 2018 to address long held concerns about the provision of unproven stem cell treatments to increasing numbers ...

Swiss authorities target 'live cell' injection clinics

March 26, 2015
Swiss health regulators announced Thursday they have launched a criminal probe into clinics suspected of giving clients potentially dangerous animal cell injections as part of anti-ageing treatments.

Medical tourism in spotlight as experts call for tighter regulation

July 5, 2017
Countries should unite to tackle unscrupulous advertising of unproven therapies involving stem cells, experts say.

Stem cell clinics and businesses are registering for-profit, pay-to-participate

July 19, 2017
The Future Science Group (FSG) journal Regenerative Medicine, today announces the publication of a new Perspective article, in which Leigh Turner (University of Minnesota, MN, USA) discusses the urgent need for careful screening ...

Recommended for you

Age-related increase in estrogen may cause common men's hernia

October 16, 2018
An age-related increase in estrogen may be the culprit behind inguinal hernias, a condition common among elderly men that often requires corrective surgery, according to a Northwestern Medicine study was published Oct. 15 ...

New findings cast light on lymphatic system, key player in human health

October 16, 2018
Scientists at the Oklahoma Medical Research Foundation have broken new ground in understanding how the lymphatic system works, potentially opening the door for future therapies.

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Discovery of inner ear function may improve diagnosis of hearing impairment

October 15, 2018
Results from a research study published in Nature Communications show how the inner ear processes speech, something that has until now been unknown. The authors of the report include researchers from Linköping University, ...

Team's study reveals hidden lives of medical biomarkers

October 12, 2018
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.